Vancouver, British Columbia – April 20, 2021 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or... View Article
New Partnership with FourthWall Testing Vancouver, British Columbia – March 31, 2021 – Nova Mentis Life Science Corp. (CSE:... View Article
Psilocybin formulation Modulates Anxiety-Like Behaviour in Rat Autism Model Vancouver, British Columbia – March 29, 2021 – Nova Mentis Life... View Article
Vancouver, British Columbia – March 10, 2021 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or... View Article
Vancouver, British Columbia – March 3, 2021 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or... View Article
Vancouver, British Columbia – February 25, 2021 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the... View Article
Company Begins Fragile X Syndrome Treatment with its Proprietary Psilocybin Drug Vancouver, British Columbia – February 18 2021 – Nova Mentis... View Article
Vancouver, British Columbia – February 11, 2021 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or... View Article
Vancouver, British Columbia – February 09, 2021 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or... View Article
Vancouver, British Columbia – January 26, 2021 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or... View Article